Target intelligence / Profile preview

Acinetobacter baumannii surface antigens

Molecular classification
Bacterial surface protein, Lipopolysaccharide, Outer membrane protein, Porin, Siderophore receptor
01

Overview

Acinetobacter baumannii surface antigens represent a broad category of molecules located on the exterior of this Gram-negative opportunistic pathogen, including outer membrane proteins (OMPs), lipopolysaccharides (LPS), and capsular polysaccharides (Kim et al., 2021, Frontiers in Cellular and Infection Microbiology). These antigens are essential for the bacterium's survival and pathogenicity, mediating critical processes such as adhesion to host cells, biofilm development, and the acquisition of essential nutrients like iron through siderophore receptors (Singh et al., 2022, Expert Review of Vaccines). In clinical settings, these surface components are major virulence factors that allow the organism to resist desiccation, evade the host immune system, and survive in the presence of many traditional antibiotics. Consequently, they have become high-priority targets for the development of novel therapeutic interventions, particularly against carbapenem-resistant strains. Current pharmacological approaches include the use of small molecules like zosurabalpin, which inhibits the LptB2FGC complex responsible for transporting LPS to the cell surface (Pahil et al., 2024, Nature), as well as experimental monoclonal antibodies and vaccines designed to neutralize specific OMPs like OmpA or BauA. Targeting these surface-exposed structures aims to disrupt the structural integrity of the pathogen or enhance its recognition and clearance by the host's immune system.

Other names
Acinetobacter baumannii outer membrane proteinsAcinetobacter cell surface antigensAb surface antigensA. baumannii cell wall antigens
02

Mechanism of action

Inhibition of the LptB2FGC complex to block lipopolysaccharide transport to the outer membrane; Opsonization and neutralization of virulence factors; Induction of protective immune responses.

03

Biological functions

Cellular adhesionBiofilm formationNutrient transportMembrane integrityImmune evasion
04

Disease associations

InfectionPneumoniaSepsisUrinary tract infection
05

Safety considerations

Antigenic variation among clinical isolatesPotential for rapid resistance through target loss (e.g., LPS-deficient mutants)Risk of inflammatory response from bacterial lysis
06

Interacting drugs

Zosurabalpin

3 more in the full profile.

07

Biomarkers

Presence of specific outer membrane protein genes (e.g., ompA, bauA)Lipopolysaccharide acylation patternsBacterial load in clinical samples

Beyond the preview

Go deeper on Acinetobacter baumannii surface antigens.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Acinetobacter baumannii surface antigens.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call